Microbira -MAAP-IR

– Can identify microorganisms in <5 minutes from initial culture.]
– Identifies Yeasts, Gram-negative & positive bacteria without Gram staining
– Is sensitive for serotyping salmonella and non-O157 E. coli from E. coli O157:H7
– Major opportunity to assist healthcare needs in developing countries as our technology is low cost and accessible using the internet reducing the significant barriers to entry in resource-limited settings.
– UKCA IVD medical device certified
-No disposables

Placement of MAAP-IR in labs for pilot studies and to expand our existing network.

Microbira Ltd is a UK-based, limited company which has created the Microbira Advanced Analytical Platform-Infrared (MAAP-IR) -a cloud-based innovative software solution leveraging artificial intelligence (AI) coupled with spectroscopy. The technology fits all size laboratories and represents a paradigm shift in microorganism identification-rapid, universally applicable, cost-effective and sustainable identifications. MAAP-IR is applicable to clinical microbiology, veterinary pathology, the food industry, and the environment. This infrared, internet-based solution achieves rapid identification of microorganisms directly from microorganism cultures and positive blood cultures, enhancing patient care and potentially reducing antimicrobial resistance.
Across a group of 38 species, our technology has demonstrated an average 99% success rate for Gram identification, an average 92% success rate for correct genus identification, and an 84% success rate for species-level identification.

Tailored prediction models for research use .MAAP-IR ‘s versatility enables Microbira to create prediction models for our clients.
Specific models will be available for veterinary and food pathogens during 2024.

Microbira is piloting a method of microorganism identification directly from positive blood cultures. This is vital for bloodstream infections and critical care patients, with a 20-minute sample prep leading to rapid results.